These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 22563234)
1. Expression of Luteinizing Hormone Receptor in the Gastrointestinal Tract in Patients with and without Dysmotility. Hammar O; Veress B; Montgomery A; Ohlsson B Drug Target Insights; 2012; 6():13-8. PubMed ID: 22563234 [TBL] [Abstract][Full Text] [Related]
2. Gonadotropin-Releasing Hormone and Its Physiological and Pathophysiological Roles in Relation to the Structure and Function of the Gastrointestinal Tract. Ohlsson B Eur Surg Res; 2016; 57(1-2):22-33. PubMed ID: 27089503 [TBL] [Abstract][Full Text] [Related]
3. Severe gastrointestinal dysmotility developed after treatment with gonadotropin-releasing hormone analogs. Cordeddu L; Bergvall M; Sand E; Roth B; Papadaki E; Li L; D'Amato M; Ohlsson B Scand J Gastroenterol; 2015 Mar; 50(3):291-9. PubMed ID: 25592315 [TBL] [Abstract][Full Text] [Related]
4. Depletion of enteric gonadotropin-releasing hormone is found in a few patients suffering from severe gastrointestinal dysmotility. Hammar O; Ohlsson B; Veress B; Alm R; Fredrikson GN; Montgomery A Scand J Gastroenterol; 2012 Oct; 47(10):1165-73. PubMed ID: 22835010 [TBL] [Abstract][Full Text] [Related]
5. Antibodies against gonadotropin-releasing hormone (GnRH) and destruction of enteric neurons in 3 patients suffering from gastrointestinal dysfunction. Ohlsson B; Ekblad E; Veress B; Montgomery A; Janciauskiene S BMC Gastroenterol; 2010 May; 10():48. PubMed ID: 20487533 [TBL] [Abstract][Full Text] [Related]
6. Gonadotropin-Releasing Hormone and Its Role in the Enteric Nervous System. Ohlsson B Front Endocrinol (Lausanne); 2017; 8():110. PubMed ID: 28638366 [TBL] [Abstract][Full Text] [Related]
7. Luteinizing hormone receptors are expressed in rat myenteric neurons and mediate neuronal loss. Sand E; Voss U; Ohlsson B; Ekblad E Auton Neurosci; 2015 Dec; 193():104-7. PubMed ID: 26480825 [TBL] [Abstract][Full Text] [Related]
8. Expression and distribution of GnRH, LH, and FSH and their receptors in gastrointestinal tract of man and rat. Sand E; Bergvall M; Ekblad E; D'Amato M; Ohlsson B Regul Pept; 2013 Nov; 187():24-8. PubMed ID: 24103690 [TBL] [Abstract][Full Text] [Related]
9. Gonadotropin-releasing hormone analog buserelin causes neuronal loss in rat gastrointestinal tract. Sand E; Voss U; Hammar O; Alm R; Fredrikson GN; Ohlsson B; Ekblad E Cell Tissue Res; 2013 Mar; 351(3):521-34. PubMed ID: 23254679 [TBL] [Abstract][Full Text] [Related]
10. The Expression of Serum Antibodies Against Gonadotropin-releasing Hormone (GnRH1), Progonadoliberin-2, Luteinizing Hormone (LH), and Related Receptors in Patients with Gastrointestinal Dysfunction or Diabetes Mellitus. Roth B; Berntorp K; Ohlsson B Drug Target Insights; 2014; 8():45-50. PubMed ID: 25452692 [TBL] [Abstract][Full Text] [Related]
11. Chronic intestinal pseudo-obstruction due to buserelin-induced formation of anti-GnRH antibodies. Ohlsson B; Veress B; Janciauskiene S; Montgomery A; Haglund M; Wallmark A Gastroenterology; 2007 Jan; 132(1):45-51. PubMed ID: 17241858 [TBL] [Abstract][Full Text] [Related]
12. Patients with irritable bowel syndrome and dysmotility express antibodies against gonadotropin-releasing hormone in serum. Ohlsson B; Sjöberg K; Alm R; Fredrikson GN Neurogastroenterol Motil; 2011 Nov; 23(11):1000-6, e459. PubMed ID: 21714833 [TBL] [Abstract][Full Text] [Related]
13. Autoantibodies and gastrointestinal symptoms in infertile women in relation to in vitro fertilization. Hammar O; Roth B; Bengtsson M; Mandl T; Ohlsson B BMC Pregnancy Childbirth; 2013 Nov; 13():201. PubMed ID: 24191889 [TBL] [Abstract][Full Text] [Related]
14. Autoantibodies common in patients with gastrointestinal diseases are not found in patients with endometriosis: A cross-sectional study. Ek M; Roth B; Valentin L; Nordengren J; Ohlsson B Eur J Obstet Gynecol Reprod Biol; 2019 Sep; 240():370-374. PubMed ID: 31213335 [TBL] [Abstract][Full Text] [Related]
15. Enteric neuron density correlates with clinical features of severe gut dysmotility. Boschetti E; Malagelada C; Accarino A; Malagelada JR; Cogliandro RF; Gori A; Bonora E; Giancola F; Bianco F; Tugnoli V; Clavenzani P; Azpiroz F; Stanghellini V; Sternini C; De Giorgio R Am J Physiol Gastrointest Liver Physiol; 2019 Dec; 317(6):G793-G801. PubMed ID: 31545923 [TBL] [Abstract][Full Text] [Related]
16. Pituitary function is altered during the same cycle in women with polycystic ovary syndrome treated with continuous or cyclic oral contraceptives or a gonadotropin-releasing hormone agonist. Ruchhoft EA; Elkind-Hirsch KE; Malinak R Fertil Steril; 1996 Jul; 66(1):54-60. PubMed ID: 8752611 [TBL] [Abstract][Full Text] [Related]
17. Novel presence of luteinizing hormone/human chorionic gonadotropin (hCG) receptors and the down-regulating action of hCG on gonadotropin-releasing hormone gene expression in immortalized hypothalamic GT1-7 neurons. Lei ZM; Rao CV Mol Endocrinol; 1994 Aug; 8(8):1111-21. PubMed ID: 7997235 [TBL] [Abstract][Full Text] [Related]
18. The chronic intestinal pseudo-obstruction subtype has prognostic significance in patients with severe gastrointestinal dysmotility related intestinal failure. Vasant DH; Kalaiselvan R; Ablett J; Bond A; Abraham A; Teubner A; Green D; Paine PA; Lal S Clin Nutr; 2018 Dec; 37(6 Pt A):1967-1975. PubMed ID: 30290972 [TBL] [Abstract][Full Text] [Related]
19. New insights into the understanding of gastrointestinal dysmotility. Ohlsson B; Janciauskiene S Drug Target Insights; 2007; 2():229-37. PubMed ID: 21901077 [TBL] [Abstract][Full Text] [Related]
20. Pseudo-obstruction, enteric dysmotility and irritable bowel syndrome. Lindberg G Best Pract Res Clin Gastroenterol; 2019; 40-41():101635. PubMed ID: 31594655 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]